Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Elisabetta Clementi

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
International Journal of Molecular Sciences|July 12, 2025
Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental ModelsMaria De Carluccio, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
Neuroscience and Biobehavioral Reviews|May 10, 2021
Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disordersFabrizio Michetti, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
International Journal of Molecular Sciences|February 11, 2023
S100B Affects Gut Microbiota BiodiversityVincenzo Romano Spica, Federica Valeriani, Massimiliano Orsini, et al.
International Journal of Molecular Sciences|December 24, 2021
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune EncephalomyelitisChiara Camponeschi, Maria De Carluccio, Susanna Amadio, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
International Journal of Molecular Sciences|July 12, 2025
Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental ModelsMaria De Carluccio, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
Neuroscience and Biobehavioral Reviews|May 10, 2021
Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disordersFabrizio Michetti, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
International Journal of Molecular Sciences|February 11, 2023
S100B Affects Gut Microbiota BiodiversityVincenzo Romano Spica, Federica Valeriani, Massimiliano Orsini, et al.
International Journal of Molecular Sciences|December 24, 2021
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune EncephalomyelitisChiara Camponeschi, Maria De Carluccio, Susanna Amadio, et al.
Pageof 4